News
02-27-2011, 03:10 PM
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
More... (http://www.news-medical.net/news/20110227/Avastin-debate-spills-over-until-June-FDA-hearing.aspx)
More... (http://www.news-medical.net/news/20110227/Avastin-debate-spills-over-until-June-FDA-hearing.aspx)